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Abstract
InTrodUcTIon: Opioids and Non-steroidal anti-inflammatory drugs (NSAID) are used to manage low back 
pain. However, it has been reported in some researches that opioids have fewer side effects than NSAID. 
MeTHods: Patient files of all the patients admitted to the emergency department of Ufuk University ethics 
committee on 23.03.2018 and applied with severe nontraumatic low back pain between 01.01.2015 and 
01.01.2016 were examined retrospectively. It was aimed to evaluate the efficacy of these two drugs in the 
treatment of pain by evaluating the responses of these patients with visual analogue scale scales. 
resULTs: A total of 138 patients among 911 patients experiencing low back pain were included in the study. 
81 patients received 75 mg of diclofenac sodium therapy alone, 57 patients received only Petidin hydro-
chloride treatment. 64 (46.4%) of the patients were male and 74 (53.6%) were female. It was found that 
there was no statistically significant correlation between pain scores of 75 mg of diclofenac sodium imide 
treatment applied and Pethidine hydrochloride applied patient groups (p > 0.05). There was no statistically 
significant correlation between pain scores and genders of 75 mg of diclofenac sodium imide treatment 
applied and Pethidine hydrochloride applied patient groups (p > 0.05). The difference between patients’ 
referral scores and pain scores after 45 minutes (75 mg diclofenac sodium imide and petidine hydrochloride 
imide) were found to be statistically insignificant (p > 0.05). There was no statistically significant difference 
in the analyzed results of the efficacy of 75 mg diclofenac sodium treatment related to gender (p > 0.05). 
There was no statistically significant difference in the analyzed results of the efficacy of Pethidine hydrochlo-
ride treatment related to sex (p > 0.05). 
concLUsIons: Opioids have fewer side effects than NSAIDs in short period management of the pain, and 
they may be used for low back pain management in emergency services instead of NSAIDs.
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InTrodUcTIon
Pain is one of the most common symptoms required 
for emergency service treatment. Low back pain is 
the most common musculoskeletal system disease 
[1]. Its prevalence was reported as 4.39% in a sys-
tematic meta-analysis of 21 articles and 19 research-
es between 2000–2016 [2]. 
Individual pain experience varies depending on 
the current and past medical history, physical and 
emotional state, cognitional health, description of 
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the pain, culture and environment. Pain is described 
as complex phenomena defined by physiologic, cul-
tural and social-demographic factors [3].
The basic principle of effective pharmacologic 
pain management in emergency service is the selec-
tion of an agent suitable to pain level, having rapid 
analgesic activity outset, easy and safety to use. Pain 
scales must be used to evaluate the level of the pain. 
Aims of pain scales are defining seriousness level of 
pain, selecting proper analgesic agent type, its dos-
age and using properties. It is known that reporting 
of the pain by the patient is the most reliable indica-
tor. In literature, the Visual Analog Scale (VAS) and 
Numeric Rating Scale (NRS), and both of them have 
high correlation [4].
Patients with acute pain in emergency depart-
ments are advised to provide appropriate analgesia 
according to the patient’s pain severity. The first pri-
ority in Emergency care should be managing pain. 
Pain management should be initiated as soon as 
the patient first met and should be terminated by 
the application of the correct analgesic drug at the 
appropriate time. In the treatment of pain, the se-
lection of the agent should be decided according 
to the severity and clinical condition of the patient. 
Non-steroidal anti-inflammatory drugs (NSAID) and 
oral opioids should be preferred in mild-to-moder-
ate pain and parenteral opioids in severe pain [5].
The analgesic activity of opioids for acute pain is 
well established, but there have not been sufficient 
data on back pain. It is reported that opioids may be 
used for short-term treatment of severe pain in the 
guidelines of the National Institute of Health and 
Care Excellence (NICE) and the American College of 
Physicians and the American Pain Society (ACP/APS) 
[6] It is recommended that opioids should be used 
with caution in severe pain that can not be controlled 
by NSAIDs and acetaminophen [6]. However, the po-
tential benefits and losses of opioid analgesics should 
be carefully compared before treatment begins.
In this study, we aimed to evaluate the efficacy 
of 75 mg of diclofenac sodium, which is an opioid 
Pethidine hydrochloride and NSAID, in the treat-
ment of patients with emergency nontraumatic low 
back pain.
MeTHods
In the research, patient files of all patients admit-
ted to the emergency department of Ufuk Univer-
sity ethics committee on 23.03.2018 and applied 
with severe nontraumatic low back pain between 
01.01.2015 and 01.01.2016 were examined retro-
spectively.
This study was conducted in concordance with 
the World Medical Association Declaration of Hel-
sinki “Ethical Principles for Medical Research Involv-
ing Human Subjects”, (amended in October 2013). 
A consent form wasn’t obtained from the patients 
due to the retrospective nature of the study. This 
study was approved by the ethics committee of 
Ufuk University.
Visual analogue scales numerically represented 
as 7 and above, with the exclusion criteria for pa-
tients aged 18–65 years; 100mg of pediatric alco-
holic disease after exclusion of malignancy, chronic 
renal failure, diabetes mellitus, cardiovascular dis-
eases, liver failure, hematological diseases, active in-
fection, smoking, alcohol dependence, autoimmune 
disease, cerebrovascular events, pulmonary embo-
lism, pregnancy, hydrochloride intramuscular and 
75 mg diclofenac sodium intramuscular only were 
included in the study. It was aimed to evaluate the 
efficacy of these two drugs in the treatment of pain 
by evaluating the responses of these patients with 
visual analogue scale scales. All these data were ana-
lyzed statistically using SPSS. A p-value < 0.05 was 
considered as statistically significant.
resULTs
In total, 22,680 patients between 01.01.2015 and 
01.01.2016 were applied to our emergency service. 
Out of these patients 911 had a low back pain di-
agnosis. 315 patients were not able to obtain visual 
analogue scale file record before or after treatment. 
253 patients had combined drug use for low back 
pain or use of a different NSAID and Opioid agent. 
205 patients were excluded because ofthe exclusion 
criteria of the study. A total of 138 patients having 
the study criteria were included in the study with the 
complaint of nontraumatic low back pain. Eighty-
one patients received 75 mg of diclofenac sodium 
therapy alone, 57 patients received only Petihdine 
hydrochloride treatment. 64 of the patients (46.4%) 
were male and 74 were female (53.6%).
In our study, nontraumatic low back pain and 
emergency pain at the time of admission were not 
statistically related to gender (p > 0.05). The phy-
sician’s desire to choose drug or NSAID treatment 
was not associated with pain severity at the time 
of admission to the emergency department. There 
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was no statistically significant correlation between 
pain scores of 75 mg of diclofenac sodium imide 
treatment applied and Pethidine hydrochloride 
applied patient groups (p > 0.05) (Tab. 1). There 
was no statistically significant correlation between 
pain scores and genders of 75 mg of diclofenac 
sodium imide treatment applied and Pethidine 
hydrochloride applied patient groups (p > 0.05) 
(Tab. 2).
The difference between patients’ referral scores 
and pain scores after 45 minutes (75 mg diclofenac 
sodium imide and pethidine hydrochloride imide) 
were found to be statistically insignificant (p > 0.05) 
(Tab. 3).
There was no statistically significant difference 
in the analyzed results of the efficacy of 75 of mg 
diclofenac sodium treatment related to gender 
(p > 0.495). Similarly, there was no statistically sig-
nificant difference in the analyzed results of the 
efficacy of Pethidine hydrochloride treatment related 
to sex (p: 0.974) (Tab. 4).
dIscUssIon
In a study conducted by Gottlieb et al., Opioid, 
myorelaxant, and placebo were given by oral route 
along with NSAID for patients with low back pain 
[7]. There was no difference in the treatments given 
for pain activity but there was a significant differ-
ence in the opioid group in terms of side effect. 
In a systematic review conducted by White et al it 
was evaluated that opioids are more effective than 
placebo in chronic low back pain when compared 
to NSAID [8].
Table 1. Relationship between gender and treatment regimens according to VAS values at emergency 
department admission
Initial Pain Score
Mean %95 CI Median SE SD Min Max %25 %75 p
Sex Male (n = 64) 8.34 8.07 8.62 8 0.139 1.116 7 10 7 9 0.753
Female (n = 74) 8.28 8.03 8.54 8 0.128 1.104 7 10 7 9
Treatment Diclofenac Soium 
(n = 81)
8.26 8.02 8.5 8 0.123 1.104 7 10 7 9 0.501
Petidin
hydrochloride (n = 57)
8.39 8.09 8.68 8 0.148 1.114 7 10 9 9
Table 2. Relationship between the VAS values of the patients and the genders according to the treatment 
regimens
Final Pain Score
Gender Mean %95 CI Median SE SD Min Max 25 75 p
Diclofenac 
Soium  
(n = 81)
Male (n = 39) 8.28 7.93 8.64 8 0.176 1.099 7 10 7 9 0.829
Female (n = 42) 8,24 7.89 8.59 8 0.173 1.122 7 10 7 9
Petidin 
hydrochloride 
(n=57)
Male (n = 39) 8.44 7.96 8.92 8 0.232 1.158 7 10 7 9.5 0.764
Female (n=42) 8,34 7,95 8,74 8 0,194 1,096 7 10 7,25 9
Table 3. Relationship between Diclofenac Sodium and Pethidine Hydrochloride Treatment Effectiveness
The Difference Between Pre-Treatment And Post-Treatment Pain Severity
Mean %95 CI Median SE SD Min Max 25 75 p
Diclofenac Soium 
(n = 81)
5.86 5.55 6.16 6 0.152 1.376 3 9 5 7 0.857
Petidin
hydrochloride (n = 57)
5.87 5.40 6.34 6 0.234 1.773 2 9 5 7
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Bıyık et al. randomized 30 patients to 800 mg/day 
of gabapentin (n = 55) and 75 mg/day of diclofenac 
(n = 55) on 110 patients with chronic post-sternoto-
my chest pain and paresthesia (PCPP) with 3 months 
follow up. They reported that both gabapentin and 
diclofenac are effective in the treatment of chronic 
non-ischemic chest pain and paresthesia after sternot-
omy, without significant side effects. However, they 
found that gabapentin was superior to diclofenac and 
the effect lasted longer [9]. We think that the efficacy 
of pain in this study differs because of the use of drugs 
for a long time compared with our study.
Yeganeh Mogadama et al. found no statistically 
significant difference between groups of patients 
using gabapentin and diclofenac in a double-blind, 
placebo-controlled clinical trial of 90 patients for 
tonsillectomy pain management. They reported that 
both groups were effective in the treatment of pain 
compared with the placebo group. There was no 
statistically significant difference in drug side effects 
between the groups [10].
concLUsIon
The physician’s selection of drugs or NSAID treat-
ment was not associated with pain severity at the 
time of admission to the emergency department. 
On the other hand, it was found that opioids have 
fewer side effects than NSAIDs in short period man-
agement of the pain. Thus, opioids may be used for 
low back pain management in emergency services 
instead of NSAIDs.
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Table 4. Relationship between treatment responses of patients and gender according to treatment regimens
The Difference Between Pre-Treatment And Post-Treatment Pain Severity
Gender Mean %95 CI Median SE SD Min Max 25 75 p
Diclofenac 
Soium 
(n = 81)
Male (n = 39) 6.00 5.57 6.42 6 0.211 1.317 4 9 5 7 0.495
Female (n = 42) 5.73 5.29 6.18 6 0.221 1.432 3 8 5 7
Petidin
hydrochloride 
(n = 57)
Male (n = 39) 5.84 5.14 6.,53 6 0.335 1.675 2 8 4,5 7 0.974
Female (n = 42) 5.90 5.23 6.58 6 0.331 1.872 2 9 5 7
